External pharmaceutical composition
A technology of external drug and composition, which is applied in the field of external drug composition, can solve the problems of increased application, achieve the effect of less restriction, relieve or cure deformed joint disease, and excellent storage stability
Active Publication Date: 2017-02-15
KOBAYASHI PHARMA CO LTD
View PDF3 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
When diclofenac is administered orally or rectally, gastrointestinal, renal, or hepatic damage may occur as a side effect, and
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Login to View More
PUM
Login to View More
Abstract
To provide a pharmaceutical technique which inhibits yellowing caused under temporal or high temperature conditions, while containing diclofenac and/or a salt thereof and tocopherol and/or a derivative thereof, in an external pharmaceutical composition which contains water, to enable having an excellent storage stability. In an external pharmaceutical composition containing diclofenac and/or a salt thereof, tocopherol and/or a derivative thereof, and water, containing lactic acid and/or a salt thereof can inhibit yellowing caused under temporal or high temperature conditions to enable having an excellent storage stability.
Description
technical field [0001] The present invention relates to an external pharmaceutical composition containing diclofenac and / or a salt thereof, tocopherol and / or a derivative thereof, and water, which suppresses yellowing over time or under high temperature conditions and has excellent storage stability. Background technique [0002] In modern society, the number of people suffering from shoulder pain, muscle pain, joint pain, etc. has increased due to the same posture for a long time, excessive stress, and lack of exercise due to the spread of OA equipment. Conventionally, for such shoulder pain, muscle and joint pain, etc., anti-inflammatory analgesics have been applied in order to suppress inflammation in the affected area and improve symptoms. [0003] Conventionally, non-steroidal anti-inflammatory drugs such as diclofenac, felbinac, dexamethasone, indomethacin, and ibuprofen have been put into practical use as anti-inflammatory analgesics. Among these non-steroidal anti-i...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K31/196A61K9/08A61K31/355A61K47/10A61K47/12A61P19/02A61P29/00A61P43/00
CPCA61K47/10A61K47/12A61K9/08A61K31/196A61K31/355A61K9/0014A61K31/19A61P19/02A61P29/00A61P43/00A61K2300/00
Inventor 阿度和克今井歌子薇
Owner KOBAYASHI PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com